Skip to main content
Caplight Logo









Readout Capital

Readout Capital

Washington D.C.readoutcap.com

Overview

Readout Capital is a biotechnology-focused investment firm that employs a long/short equity strategy, conducting fundamental research to invest in both public and private life sciences companies.

Year Founded

2023

Portfolio Companies

1

Investments

Readout Capital investments
CompanyDateStageLead
Epicrispr BiotechnologiesAug 2026Series CCo-investor

Key People

James Dahlman

Chief Scientific Officer

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersWashington D.C.
Year Founded2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?